Texas Capital Bancshares, Inc. (TCBIO) Financials
TCBIO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 31.6 billion | 28.3 billion |
| June 30, 2024 | 29.9 billion | 26.7 billion |
| March 31, 2024 | 29.2 billion | 26.0 billion |
| Dec. 31, 2023 | 28.4 billion | 25.2 billion |
TCBIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | 318.1 million | 6.5 million |
| June 30, 2024 | 11.4 million | 6.2 million |
| March 31, 2024 | 60.2 million | 8.5 million |
| Dec. 31, 2023 | 183.9 million | 6.3 million |
TCBIO Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| Sept. 30, 2024 | -61.3 million |
| June 30, 2024 | 41.7 million |
| March 31, 2024 | 26.1 million |
| Dec. 31, 2023 | 20.2 million |
TCBIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 3.8 billion | 660.2 million | - |
| June 30, 2024 | 2.8 billion | 660.0 million | - |
| March 31, 2024 | 3.7 billion | 859.8 million | - |
| Dec. 31, 2023 | 6.5 billion | 859.1 million | - |
TCBIO Shares Outstanding
TCBIO Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | 15.2 million | - | 131.9 million | 5.9 million |
| June 30, 2024 | 22.2 million | - | 130.4 million | 6.0 million |
| March 31, 2024 | 20.0 million | - | 143.2 million | 6.0 million |
| Dec. 31, 2023 | 3.7 million | - | 138.8 million | 5.7 million |
TCBIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | 125.3 million | -327.2 million |
| June 30, 2024 | 472.6 million | 50.4 million |
| March 31, 2024 | 455.0 million | 37.6 million |
| Dec. 31, 2023 | 245.9 million | 123.9 million |
TCBIO
Price: $20.59
52 week price:
5-year range yield:
Forward Dividend Yield: 6.98%
Payout Ratio: 36.31%
Payout Ratio Range:
Dividend Per Share: 1.44 USD
Earnings Per Share: 3.96 USD
P/E Ratio: 5.15
Exchange: NMS
Sector: Financial Services
Industry: Banks - Regional
Volume: 11200
Market Capitalization: 938.7 million
Average Dividend Frequency: 4
Years Paying Dividends: 5